Esperion Therapeutics | ESPR - Zobowiązania Handlowe





Zobowiązania Handlowe Zmiana Data
AbbVie USD 3.59B 28.65B 2025-12
Alnylam Pharmaceuticals USD 126.63M 10.91M 2026-03
Alterity Therapeutics Limited AUD 1.07M 203.72K 2025-12
Amarin USD 48.15M 2.8M 2026-03
Amgen USD 19.52B 1.37B 2026-03
Biogen USD 358.5M 73.5M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Cipla INR 30.35B 1.98B 2025-09
CSL USD 3.17B 290M 2025-12
Cytokinetics USD 24.71M 80.91M 2026-03
Daiichi Sankyo JPY 568.5B 16.84B 2025-12
Eli Lilly USD 5.03B 350M 2026-03
Esperion Therapeutics USD 65.07M 12.44M 2025-12
Geron USD 11.26M 146K 2025-12
Grifols EUR 987.75M 47.87M 2025-12
Halozyme Therapeutics USD 20.9M 5.54M 2025-12
Heron Therapeutics USD 8.99M 3.02M 2025-12
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
Merck USD 3.86B 541M 2026-03
Minerva Neurosciences USD 640K 305K 2025-12
Moderna USD 161M 156M 2026-03
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Pfizer USD 4.51B 734M 2026-03
PTC Therapeutics USD 45.49M 8.87M 2025-12
Puma Biotechnology USD 6.39M 962K 2025-09
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Sanofi EUR 22.71B 219M 2026-03
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
United Therapeutics USD 7.1M 460.9M 2025-12
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12